Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. Lobbyist name (consultant or in-house lobbyist): ELSTON, MURRAY OR;
  2. Responsible officer name: ELSTON, MURRAY
Share this search Create an alert

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (22)
Results: 1-22 | Export
  1. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 10 of 10 (2004-01-06 to 2004-01-06)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 6
  2. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 9 of 10 (2003-06-16 to 2004-01-06)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 6
  3. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 8 of 10 (2002-12-02 to 2003-06-16)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 6
  4. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 7 of 10 (2002-06-04 to 2002-12-02)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 5
  5. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 6 of 10 (2001-11-20 to 2002-06-04)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 4
  6. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 5 of 10 (2001-03-05 to 2001-10-05)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 16
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 4
  7. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 4 of 10 (2000-07-31 to 2001-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 16
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 8
  8. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 3 of 10 (2000-01-11 to 2000-07-31)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 15
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 10
  9. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 2 of 10 (1999-07-07 to 2000-01-11)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 15
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 8
  10. Bruce Power
    Type: In-house Corporation
    Responsible officer: Duncan Hawthorne, President & Chief Executive Officer (CEO)
    Registration: 7 of 46 (2010-07-19 to 2011-12-01)
    Posted: 2010-08-16
    Subject matter details: 11
    Government institutions: 16
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  11. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 1 of 10 (1998-12-10 to 1999-07-06)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 15
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 8
  12. Bruce Power
    Type: In-house Corporation
    Responsible officer: Duncan Hawthorne, President & Chief Executive Officer (CEO)
    Registration: 6 of 46 (2008-09-02 to 2010-07-19)
    Posted: 2010-01-19
    Subject matter details: 10
    Government institutions: 15
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 6
  13. Canadian Nuclear Association / Association nucléaire canadienne
    Type: In-house Organization
    Responsible officer: Murray Elston, President & CEO
    Registration: 7 of 42 (2008-03-14 to 2009-05-05)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 8
    Government institutions: 55
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 4
  14. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MARC DESMARAIS, V.P. FEDERAL GOVERNMENT AFFAIRS
    Registration: 2 of 2 (2004-08-19 to 2004-08-19)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 7
  15. Canadian Nuclear Association / Association nucléaire canadienne
    Type: In-house Organization
    Responsible officer: Murray Elston, President & CEO
    Registration: 6 of 42 (2007-09-17 to 2008-03-14)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 8
    Government institutions: 55
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 4
  16. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: MARC DESMARAIS, V.P. FEDERAL GOVERNMENT AFFAIRS
    Registration: 1 of 2 (2004-01-13 to 2004-08-09)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 6
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 7
  17. Canadian Nuclear Association / Association nucléaire canadienne
    Type: In-house Organization
    Responsible officer: Murray Elston, President & CEO
    Registration: 5 of 42 (2007-03-14 to 2007-09-17)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 4
    Government institutions: 55
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 4
  18. Canadian Nuclear Association / Association nucléaire canadienne
    Type: In-house Organization
    Responsible officer: Murray Elston, President & CEO
    Registration: 4 of 42 (2006-09-25 to 2007-03-14)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 4
    Government institutions: 55
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 4
  19. Canadian Nuclear Association / Association nucléaire canadienne
    Type: In-house Organization
    Responsible officer: Murray Elston, President & CEO
    Registration: 3 of 42 (2006-03-29 to 2006-09-25)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 4
    Government institutions: 55
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 4
  20. Canadian Nuclear Association / Association nucléaire canadienne
    Type: In-house Organization
    Responsible officer: Murray Elston, President & CEO
    Registration: 2 of 42 (2005-08-17 to 2006-03-29)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 4
    Government institutions: 55
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 4
  21. Canadian Nuclear Association / Association nucléaire canadienne
    Type: In-house Organization
    Responsible officer: MURRAY ELSTON, PRESIDENT AND CEO
    Registration: 1 of 42 (2004-05-31 to 2004-12-16)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 8
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 2
  22. CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
    Type: In-house Organization
    Responsible officer: JUDY EROLA, PRESIDENT
    Registration: 5 of 5 (1998-07-02 to 1998-12-10)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 2
    Government institutions: 15
    Communication techniques: 5
    Government funding: No
    Employees who lobby: 11

Date Modified: